For sales

📢 Highlights from May 05 to 09 in the world of pharma and healthcare! 🗞️👀

Vyuhpharma Alchemab (Collaboration) Alchemab licensed its ATLX-1282 program to Eli Lilly, with Alchemab lead early Phase 1 trials and Lilly will handle further development and commercialization GRIN Therapeutics (EMA, CHMP Opinion, Orphan designation) EMA CHMP granted a positive orphan designation for GRIN Therapeutics radiprodil, following its recent PRIME status from EMA and Breakthrough Therapy and Orphan Drug designations from the FDA GeneFab (Collaboration, Clinical Manufacturing, Auto immune disease) GeneFab partnered with RegCell to support the US clinical manufacturing of RegCell's Treg therapies for autoimmune diseases Genezen (Collaboration, CAR-T therapy) Genezen and Optieum Biotechnologies form strategic partnership to advance cGMP manufacturing of OPTF01, a next-generation CAR-T therapy targeting glioblastoma Mersana (Layoff, R&D) Mersana restructures to extend runway, prioritize Emi-Le in breast cancer; 55% workforce cut is expected by Q3 2025 ProBioGen (Collaboration, Cell line, Biosimilar) ProBioGen and Polpharma Biologics partner for cell line development to advance biosimilar pipeline, supporting the expansion of their growing
Download

Connect with us

Please fill in the information below, and we'll get back to you.